TransEnterix CEO Talks But Doesn't Say Much

When things go wrong, it’s best to be open, transparent, but most importantly, meaningful. But that is not the path that TransEnterix and its CEO Todd Pope are choosing to follow as was evident in the surgical robotics company’s second quarter earnings call on Friday.

Here’ s some quick background of what has gone wrong with the Research Triangle Park, North Carolina-based company. TransEnterix was widely expected to win clearance from the Food & Drug Administration for its SurgiBot in early 2016 that would have made it the only second company, after Intuitive Surgical, to have an approved surgical robot on the market.

Back to news